IRIDEX Corporation (Nasdaq: IRIX) announced the receipt of issuance of U.S. Patent No. 7,771,417, titled “Laser System with Short Pulse Characteristics And Its Method Of Use.” This patent applies to the company’s MicroPulse? technology which provides the ophthalmologist with fine dose control of laser energy during eye surgery…
More: continued here
Filed under: Eye Health on August 19th, 2010
IRIDEX Corporation (Nasdaq: IRIX) announced the receipt of issuance of U.S. Patent No. 7,771,417, titled “Laser System with Short Pulse Characteristics And Its Method Of Use.” This patent applies to the company’s MicroPulse? technology which provides the ophthalmologist with fine dose control of laser energy during eye surgery…
More: continued here
Filed under: Eye Health on August 19th, 2010
IRIDEX Corporation (Nasdaq: IRIX) announced the receipt of issuance of U.S. Patent No. 7,771,417, titled “Laser System with Short Pulse Characteristics And Its Method Of Use.” This patent applies to the company’s MicroPulse? technology which provides the ophthalmologist with fine dose control of laser energy during eye surgery…
More: continued here
Filed under: Eye Health on August 19th, 2010
IRIDEX Corporation (Nasdaq: IRIX) announced the receipt of issuance of U.S. Patent No. 7,771,417, titled “Laser System with Short Pulse Characteristics And Its Method Of Use.” This patent applies to the company’s MicroPulse? technology which provides the ophthalmologist with fine dose control of laser energy during eye surgery…
More: continued here
Filed under: Eye Health on August 19th, 2010
You must be logged in to post a comment.